Are pharma reps on balance a curse or a blessing to medical practices? On some days it is not unusual to believe the former, that the pharmaceutical representative is another obnoxious intrusion into ...

Is the benefit to your medical group of maintaining ongoing relationships with pharma reps worth the cost? That’s a question confronting thousands of hospitals and medical groups today. Many factors ...

The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

Nearly 60% of physicians say disease-specific leadership and corporate reputation are the most influential factors regarding which medicine they choose to prescribe to patients. The latest Brands in ...

Pharmaceutical company reps have been visiting doctors for decades to tell them about the latest drugs. But how does the practice affect patients? A group of economists tried to answer that question.

Rep. Kurt Schrader (D-Ore.), a centrist, is touting his vote for a bill empowering Medicare to negotiate prescription drug prices. He omits that he also worked to water the bill down. (Photo: Tom ...

Representative Susan Wild took to the House floor to challenge the legitimacy of recent insulin price cuts from major pharmaceutical companies and pressure the industry to reduce costs to patients on ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. Pharmaceutical executives are waking up to a hard new ...

In their heydey, drug reps had big expense budgets and would wine and dine physicians, golf with them, and give gifts to their potential physician clients. But in 2002, pressure from Congress and ...